Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083
Meredith E. Clement(Louisiana State University Health Sciences Center New Orleans), Richard Novák(Illinois College), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Juan Carlos Hinojosa Boyer, Kailazarid Gomez Feliciano(Family Health International 360), Christopher B. Hurt(University of North Carolina at Chapel Hill), Jessica Justman(Columbia University), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Kenneth H. Mayer(Miriam Hospital), Nuntisa Chotirosniramit(Chiang Mai University), Roberto C. Arduino, Keren Middelkoop(Desmond Tutu HIV Foundation), Raphael J. Landovitz(APLA Health), Trần Việt Hà(University of North Carolina at Chapel Hill), Marybeth McCauley(Family Health International 360), Sharon Mannheimer(Columbia University Irving Medical Center), James F. Rooney(Gilead Sciences (United States)), Aditya H. Gaur(St. Jude Children's Research Hospital), Albert Liu(San Francisco Department of Public Health), Mayara Secco Torres Silva(Instituto Evandro Chagas), Julie Franks(Harlem United), Roy M. Gulick(New York University), Eileen F. Dunne, Jesse L. Clark(University of Maryland, Baltimore), Ian Frank(Norwegian Womens Public Health Association), Pedro Gonzáles(Hospital Nacional Dos de Mayo), Manya Magnus(Milken Institute), Carlos del Rı́o(Emory University), Marcelo Losso(UCLA Medical Center), Ryan Kofron(APLA Health), Colleen F. Kelley(Emory University), Christopher Hall(Wellcome Sanger Institute), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alex R. Rinehart, Lydia Soto-Torres, Suwat Chariyalertsak, Sue Ellen Abdalian, José A. Bazan(The Ohio State University), Jorge A. Gallardo-Cartagena(National University of San Marcos), Robinson Cabello, Daniel Haines(Fred Hutch Cancer Center)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k